跳至主要内容
临床试验/NCT04882904
NCT04882904招募中不适用

Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects

Centre Hospitalier Universitaire de Liege2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2020年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
45
试验地点
2
主要终点
95th centile of stride length

研究概览

简要总结

ActiSLA is a monocentric academic study. Patients with amyotrophic lateral sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 20 patients with ALS.

The investigators have planned to assess patient every three months for a year. On each visit, participants will undergo a clinical examination with MRC sum score and Ashworth scores.

They will perform few tests ( 6-minutes walk test (6MWT), dynamometric measure, electromyography, Edinburgh Cognitive and Behavioural ALS Screen ) and will answer to some questionaires (dysphagia handicap scale, ALS-SFR-r).

After each visit, participants will wear Actimyo for one month daily.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically defined or probable diagnosis of ALS according to El Escorial criteria revised with Awaji's electro-diagnostic algorithm.
  • Over 18 years old.
  • Signed informed consent
  • If patient on Riluzole, the dosage should be stable for 1 month and continued throughout the study period.

排除标准

  • Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
  • Any other previous or present pathology having an impact on motor function.
  • Recent surgery or trauma (less than 6 months) in the upper or lower limbs.
  • Prior neurological, endocrine, infectious, allergic, or chronic or acute inflammatory pathology in the three weeks preceding inclusion.
  • Patients participating in an interventional clinical trial.

结局指标

主要结局

95th centile of stride length

时间窗: 1 year

95th centile of stride length obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter).

95th centile of stride velocity

时间窗: 1 year

95th centile of stride velocity obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter per second).

50th centile of stride velocity

时间窗: 1 year

50th centile of stride velocity obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter per second).

50th centile of stride length

时间窗: 1 year

50th centile of stride length obtained with a magneto-inertial sensor (Actimyo°) in real-life (meter).

次要结局

  • Upper limb function evolution in patient with ALS(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laurent Servais

Coordinator of reference center for neuromuscular diseases

Centre Hospitalier Universitaire de Liege

研究点 (2)

Loading locations...

相似试验